Liabilities in USD of NEXIEN BIOPHARMA, INC. from Q2 2014 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
NEXIEN BIOPHARMA, INC. quarterly Liabilities history and change rate from Q2 2014 to Q1 2025.
  • NEXIEN BIOPHARMA, INC. Liabilities for the quarter ending 31 Mar 2025 was $458,801.000, a 35.1% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $458,801 +$119,243 +35.1% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $423,997 +$107,185 +33.8% 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 $396,704 +$83,850 +26.8% 30 Sep 2024 10-Q 18 Nov 2024
Q2 2024 $365,432 +$70,298 +23.8% 30 Jun 2024 10-Q 14 May 2025
Q1 2024 $339,558 +$51,062 +17.7% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $316,812 +$37,520 +13.4% 31 Dec 2023 10-Q 20 Feb 2024
Q3 2023 $312,854 +$47,292 +17.8% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $295,134 +$53,011 +21.9% 30 Jun 2023 10-K 22 Oct 2024
Q1 2023 $288,496 31 Mar 2023 10-Q 17 May 2023
Q4 2022 $279,292 31 Dec 2022 10-Q 08 Feb 2023
Q3 2022 $265,562 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $242,123 +$202,807 +5.2% 30 Jun 2022 10-K 28 Sep 2023
Q2 2021 $39,316 +$10,165 +34.9% 30 Jun 2021 10-K 28 Sep 2022
Q1 2021 $12,748 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $30,382 31 Dec 2020 10-Q 11 Feb 2021
Q2 2020 $29,151 30 Jun 2020 10-Q 05 May 2021
Q2 2017 $91,576 +$21,673 +31% 30 Jun 2017 10-K 31 Jul 2017
Q1 2017 $86,670 +$21,550 +33.1% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 $81,396 +$21,520 +35.9% 31 Dec 2016 10-Q 06 Feb 2017
Q3 2016 $76,606 +$21,207 +38.3% 30 Sep 2016 10-Q 19 Oct 2016
Q2 2016 $69,903 +$20,988 +42.9% 30 Jun 2016 10-K 31 Jul 2017
Q1 2016 $65,120 +$24,304 +59.5% 31 Mar 2016 10-Q 13 Apr 2016
Q4 2015 $59,876 +$19,060 +46.7% 31 Dec 2015 10-Q 04 Feb 2016
Q3 2015 $55,399 30 Sep 2015 10-Q 14 Oct 2015
Q2 2015 $48,915 +$48,431 +100.1% 30 Jun 2015 10-K 28 Sep 2016
Q1 2015 $40,816 31 Mar 2015 10-Q 06 May 2015
Q4 2014 $40,816 31 Dec 2014 10-Q 13 Feb 2015
Q2 2014 $484 30 Jun 2014 10-K 15 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.